CL2019003179A1 - Elimination of serine proteases by treatment with finely divided silicon dioxide. (divisional request 201203291) - Google Patents

Elimination of serine proteases by treatment with finely divided silicon dioxide. (divisional request 201203291)

Info

Publication number
CL2019003179A1
CL2019003179A1 CL2019003179A CL2019003179A CL2019003179A1 CL 2019003179 A1 CL2019003179 A1 CL 2019003179A1 CL 2019003179 A CL2019003179 A CL 2019003179A CL 2019003179 A CL2019003179 A CL 2019003179A CL 2019003179 A1 CL2019003179 A1 CL 2019003179A1
Authority
CL
Chile
Prior art keywords
serine proteases
serine
plasma
elimination
treatment
Prior art date
Application number
CL2019003179A
Other languages
Spanish (es)
Inventor
Sonja Svatos
Wolfgang Teschner
Hans-Peter Schwarz
Ruth Madlener
Alfred Weber
Azra Pljevljakovic
Original Assignee
Baxalta GmbH
Baxalta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010202125A external-priority patent/AU2010202125B1/en
Priority claimed from US12/842,944 external-priority patent/US8304524B2/en
Application filed by Baxalta GmbH, Baxalta Inc filed Critical Baxalta GmbH
Publication of CL2019003179A1 publication Critical patent/CL2019003179A1/en

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

MÉTODOS PARA REDUCIR EL CONTENIDO DE SERINA PROTEASAS Y/O DE ZIMÓGENOS DE SERINA PROTEASAS DE UNA COMPOSICIÓN DE PROTEÍNAS DERIVADAS DE PLASMA. TAMBIÉN SE PROVEEN MÉTODOS DE ELABORACIÓN DE COMPOSICIONES DE PROTEÍNAS DERIVADAS DE PLASMA CON UN CONTENIDO REDUCIDO DE SERINA PROTEASAS Y/O DE ZIMÓQENOS DE SERINA PROTEASAS. ENTRE OTROS ASPECTOS, LA PRESENTE INVENCIÓN PROVEE COMPOSICIONES ACUOSAS Y LIOFILIZADAS DE PROTEÍNAS DERIVADAS DE PLASMA CON UN CONTENIDO REDUCIDO DE SERINA PROTEASAS Y/O ZIMÓQENOS DE SERINA PROTEASAS. OTROS ASPECTOS INCLUYEN MÉTODOS PARA TRATAR, MANEJAR Y/O PREVENIR UNA ENFERMEDAD QUE COMPRENDE LA ADMINISTRACIÓN DE UNA COMPOSICIÓN DE PROTEÍNAS DERIVADAS DE PLASMA CON UN CONTENIDO REDUCIDO DE SERINA PROTEASAS O DE ZIMÓQENOS DE SERINA PROTEASAS.METHODS FOR REDUCING THE CONTENT OF SERINE PROTEASAS AND / OR OF SERINE PROTEASES ZYMOGEN FROM A COMPOSITION OF PROTEINS DERIVED FROM PLASMA. IT ALSO PROVIDES METHODS FOR THE ELABORATION OF PROTEIN COMPOSITIONS DERIVED FROM PLASMA WITH A REDUCED CONTENT OF SERINE PROTEASAS AND / OR OF SERINE PROTEASES ZYMOCENES. AMONG OTHER ASPECTS, THE PRESENT INVENTION PROVIDES AQUEOUS AND LYOPHILIZED COMPOSITIONS OF PROTEINS DERIVED FROM PLASMA WITH A REDUCED CONTENT OF SERINE PROTEASES AND / OR ZYMOQENES OF SERINE PROTEASES. OTHER ASPECTS INCLUDE METHODS TO TREAT, MANAGE AND / OR PREVENT A DISEASE INVOLVING THE ADMINISTRATION OF A COMPOSITION OF PLASMA-DERIVED PROTEINS WITH A REDUCED CONTENT OF SERINE PROTEASES OR SERINE PROTEAS ZYMOQENES.

CL2019003179A 2010-05-26 2019-11-06 Elimination of serine proteases by treatment with finely divided silicon dioxide. (divisional request 201203291) CL2019003179A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010202125A AU2010202125B1 (en) 2010-05-26 2010-05-26 A method to produce an immunoglobulin preparation with improved yield
US45636510A 2010-05-27 2010-05-27
US12/842,944 US8304524B2 (en) 2009-07-23 2010-07-23 Manufacture of factor H (FH) and FH-derivatives from plasma

Publications (1)

Publication Number Publication Date
CL2019003179A1 true CL2019003179A1 (en) 2020-03-06

Family

ID=70006135

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019003179A CL2019003179A1 (en) 2010-05-26 2019-11-06 Elimination of serine proteases by treatment with finely divided silicon dioxide. (divisional request 201203291)

Country Status (1)

Country Link
CL (1) CL2019003179A1 (en)

Similar Documents

Publication Publication Date Title
CO6660439A2 (en) Removal of serine protease by treatment with finely divided silicone dioxide
WO2011150284A3 (en) Removal of serine proteases by treatment with finely divided silicon dioxide
BR112013028440A2 (en) compositions and methods comprising serine protease variants
BR112013027963A2 (en) "Subtilisin variant with proteolytic activity, nucleic acid, expression vector, host cell, composition and cleaning method".
MX2023008320A (en) Cleaning and disinfecting composition.
MX2010004454A (en) Anti-pcsk9 and methods for treating lipid and cholesterol disorders.
ECSP045191A (en) "NEW PEPTIDES AS INHIBITORS OF THE SERINE PROTEASE NS3 OF THE VIRUS OF HEPATITIS C"
MX339402B (en) Compositions and methods comprising serine protease variants.
MX351414B (en) Pharmaceutical composition for treatment and/or prevention of pancreatic cancer.
BR112015010104A2 (en) THERMOLYSIN ENZYME VARIANT, COMPOSITION AND CLEANING METHOD
PH12014500053A1 (en) Proteasome inhibitors
WO2008033562A3 (en) Kinase inhibitor compounds
NO20064976L (en) Azanidols useful as inhibitors of rock and other protein kinases
CR9949A (en) 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITORS (FLAP)
NZ601521A (en) Trypsin-like serine protease inhibitors, and their preparation and use
ATE497961T1 (en) COMPOUNDS SUITABLE AS PROTEIN KINASE INHIBITORS
EP2069377A4 (en) Methods and compositions for the treatment of skin diseases and disorders
JO2963B1 (en) Reconstituted Surfactants Having Improved Properties
MX2010002769A (en) Recombinant preparation of selected bromelain fractions.
MX2014012285A (en) Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor.
MA32183B1 (en) Hydroxylamine pyrimidylcyclopentane is used as akt protein kinase inhibitors
MX2013004906A (en) Novel specific hcv ns3 protease inhibitors.
TW200730190A (en) New combination to treat liver fibrosis
MX2018012178A (en) Conjugated c1 esterase inhibitor and uses thereof.
ATE528309T1 (en) COMPOUNDS SUITABLE AS PROTEIN KINASE INHIBITORS